Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment. - Gisslinger H; Klade C; Georgiev P; Krochmalczyk D; Gercheva-Kyuchukova L; Egyed M; Dulicek P; Illes A; Pylypenko H; Sivcheva L; Mayer J; Yablokova V; et al. (Leukemia, 2023)